Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer

Lecia V. Sequist, Thomas J. Lynch, Jennifer S. Temel et al.|Journal of Thoracic Oncology|2009

Cited by 19